PD
PD-Rx Pharmaceuticals, Inc.
PDRX · OTC
$3.10 +0.00% (+$0.00)
Market Cap $5.32M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$3.55
14.5% upside
Current Price
$3.1
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PDRX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Valuation
100 /100
Cheap P/S 0.29x
P/B 0.52x
P/FCF 6.97x
Growth
1 /100
Declining Rev. growth 13.87%
FCF growth 34.27%
Book val. growth 3.38%
Profitability
10 /100
Weak Gross margin 0.00%
Net margin 1.40%
Op. margin 2.60%
Quality
50 /100
Average ROA 2.15%
Asset turnover 1.53x
ROIC N/A
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 6.34x
Int. coverage N/A
Stability
26 /100
Unstable Beta 1,696,040.77x
Rev. volatility 11.57%
EPS volatility 382.44%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PDRX
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Robert D. Holsey
Employees
142
Headquarters
Oklahoma City